In the third year of Pink Bloom Day, Johnson & Johnson supported the Primary Insurance Foundation's call for scientific popularization of breast reconstruction concepts

On November 27, 2022, the 2022 "Pink Bloom Day" initiated by the China Primary Health Care Foundation and supported by Johnson & Johnson Medical Technology A public health promotion activity for breast reconstruction after breast cancer surgery was held
in Shanghai.
With the theme of "Please Tell Her", the event called on all parties to give more support to breast cancer patients, scientifically popularize the concept of breast reconstruction, and provide every woman who fights breast cancer with one more choice
.

"Pink Letter" public welfare micro-movie: gather the power of society, popular science breast reconstruction

At the event, the public welfare micro-movie "Pink Letter", which focuses on breast reconstruction, infected the guests
at the scene.
Directed by young female director Huang Ji again, "Pink Letter" tells the story of the heroine after breast reconstruction and through the "pink letter" to carry out a dialogue across time and space with herself in the trough through "pink letter", profoundly showing the confusion, helplessness and sadness of women who are about to face mastectomy due to breast cancer.
But in the end, with the patiently informed doctor and the warm support of his family, he regained his confidence and hope, and bravely bloomed into a new life
.

The public welfare micro-film "Pink Letter" focusing on breast reconstruction was released (from left: Zhang Zhongchun, senior director of Johnson & Johnson Medical Technology China's MENTOR Business Unit, Wu Kejin, director of breast surgery at Fudan University Obstetrics and Gynecology Hospital, and Tao Yue, vice president of corporate communications and public affairs at Johnson & Johnson China).

The famous actress Jiang Qinqin once again served as the "Pink Bloom Public Welfare Ambassador" to speak up for women - this pink letter is the strength that women give themselves, and it is also passed on to everyone, and calls on the public to "please put.
" 'Breast reconstruction' tells more people
around you.
Let everyone who fights breast cancer have one more choice, rebuild a better life, and bloom female power
again.
”

The new version of the expert consensus: Pooling the strength of the industry, calling for advance notification of breast reconstruction as an option

According to the World Health Organization's International Agency for Research on Cancer (IARC), breast cancer has become the world's largest cancer in 2020, and the number of new breast cancer in Chinese women is as high as 420,000¹
。 Currently, more than 80% of breast cancer patients require mastectomy²
.

Compared with the high incidence of breast cancer and high surgical rate, the rate of breast conserve and breast reconstruction of Chinese women is not high
.
In October 2022, the Expert Consensus on Breast Tumor Plastic Surgery and Breast Reconstruction (2022 Edition) (hereinafter referred to as the Consensus) was released
.
Compared with the previous version, the new version of the Consensus adds important content
that patients have the right to know about breast reconstruction before surgery.
Most breast cancer patients are unaware of breast reconstruction before surgery and are not told about this option, thus missing the best time
for reconstruction.
As one of the compilers, Professor Wu Jiong, Vice President of Fudan University Cancer Hospital, appealed: "Surgeons should actively inform each patient of breast cancer treatment about the timing and method of breast reconstruction before surgery, so that they can fully understand the options for breast reconstruction after mastectomy, participate in the process, and fully understand the reconstruction process, surgical complications and even long-term risks and effects, so that patients can have one more choice
.
" ”

"As the theme of today's event 'Please Tell Her', I hope that industry colleagues can pass on the option of breast reconstruction and let patients know about such scientific solutions
.
" At the same time, promote internal communication among the doctor community, encourage more doctors to enter the field of breast reconstruction, and convey a message of care to the public, care for breast cancer patients around them, and respect their choices
.
Wu Jiong said
.

Commenting on the development of breast reconstruction surgery, Professor Wu Kejin, Director of Breast Surgery at Fudan University Obstetrics and Gynecology Hospital, said: "I call on and advocate that breast oncology surgeons should continuously improve their surgical skills in breast reconstruction and provide diversified and personalized breast reconstruction methods
for different patients.
"At the same time, hospitals should also continue to carry out surgical demonstrations of various breast reconstruction techniques, and through systematic training, more breast surgeons can be familiar with and master breast reconstruction and tumor plastic surgery techniques, so as to promote the progress of breast cancer surgery in China and improve the quality of life of
Chinese breast cancer patients.
" ”

Guests from all parties participated in the roundtable discussion "Multi-party cooperation to help patients bloom into new life" (from left: Zhang Zhongchun, Senior Director of Johnson & Johnson Medical Technology China's MENTOR Business Unit, Wu Kejin, Director of Breast Surgery, Obstetrics and Gynecology Hospital of Fudan University, and Ma Jie, Founder of Oaktree Health).

Three years of pink bloom: breast reconstruction is becoming the choice of more and more patients

This year is the third year that China Primary Health Care Foundation launched the "Pink Bloom Day", using the public welfare micro-film "Pink Letter" as the carrier, hoping to unite more industry experts, medical institutions, large health enterprises and other forces, so that more patients can feel companionship and support when fighting the disease, and encourage them to overcome difficulties and bloom bravely
.

In this regard, Ms.
Hu Ningning, former vice president of China Primary Health Care Foundation, said: "With the support of Johnson & Johnson Medical Technology, the foundation launched the 'Pink Bloom Day' public welfare activity focusing on breast reconstruction, and achieved good social effects
in the past two years 。 The event built a scientific popularization and promotion platform for breast reconstruction, disseminated the scientific concept of reconstruction, popularized relevant basic knowledge, and contributed to the promotion and popularization of breast reconstruction
.
In the future, we look forward to the blessing of more social forces and the strong appeal of the media to let breast cancer patients understand the knowledge and concept
of breast reconstruction.
At the same time, it is hoped that more primary medical institutions will popularize relevant procedures and make breast reconstruction an option
for more patients.
”

Dr.
Zhongchun Zhang, Senior Director of Johnson & Johnson MedTech China's MENTOR Business Unit, said, "We are pleased to continue to support the spirit of our credo of 'responsibility to patients and doctors' Pink Bloom Day, a meaningful public health education project, calls for attention to the prevention and treatment of breast diseases and raises public awareness
of breast reconstruction after breast cancer surgery.
In the future, Johnson & Johnson hopes to continue to work with all parties to not only make continuous breakthroughs in medical technology to improve the healthy living standards and quality of patients, but also continue to work with many partners to actively build an industry innovation ecosystem, promote positive changes, and help more breast cancer patients bravely bloom and rebuild a better life
.
”

Resources

1, Chinese Journal of Cancer Prevention and Treatment, Vol.
12, No.
5, October 2020, Chin J of Oncol Prev and Treat ，Oct 2020，Vol.
12，No.
5

2, Medical Review Vol.
28, No.
6, March 2022, Medical Recapitulate, Mar.
2022, Vol.
28,No.
6；